We are excited to announce that Juno Biomedical was selected to participate in Singularity University’s Start-up Accelerator program! This is an incredible opportunity to accelerate the availability of our technology to people around the world who suffer from neurological damage caused by stroke.
Singularity University’s Accelerator Program is designed to assist companies who are working with today’s most cutting-edge technologies and who are using this technology to combat one of humanity’s grand challenges. They carefully screen and select companies based on their ability to positively impact at least one billion people worldwide.
We are honored to have been chosen as one these start-up companies who will be given a chance to work with leaders in innovation, business, and product development.
To learn more about how Juno Biomedical will benefit from SU LABS Accelerator Program, see the link below.